Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOxley, S.-
dc.contributor.authorHope-Murray, Sue-
dc.contributor.authorDick, Ronald-
dc.contributor.authorO'Brien, D.-
dc.contributor.authorSteen, Kate-
dc.description.abstractBackground. Guidelines for cardiac catheter laboratory intervention in ST-elevation myocardial infarction (STEMI) emphasise the critical need for rapid revascularisation of coronary arteries. However, it was recognised that at Epworth Richmond, there were unnecessary, lengthy delays in the transfer of inpatients with suspected STEMI to the Catheter Laboratory. In response, we initiated a process of change management to facilitate rapid Catheter Lab activation and transfer for eligible patients. Methods. We reviewed The Cardiac Society of Australia and New Zealand guidelines for the management of Acute Coronary Syndromes and adapted best practice recommendations to inpatient care. A consensus process involving widespread consultation with key stakeholders was undertaken. This resulted in the development of the Inpatient Rapid MI Pathway implemented in November 2017. Results. The Inpatient Rapid MI Pathway clarified key staff roles, responsibilities and processes related to the transfer of patients with suspected MI to the Catheter lab, with the aim of facilitating transfer within 45 minutes of the first ECG taken. Early data suggest that implementation of the Pathway has considerably decreased the time taken to transfer inpatients to the Cath Lab. Mean ‘onset of symptom to balloon time’ before was 150.8 minutes (n=9) and post implementation was 62.7 minutes (n=4). Discussion. The Inpatient Rapid MI Pathway has been effective in streamlining the early identification and treatment of patients with STEMI through clear delineation of roles and processes. Further ongoing evaluation and review is required to refine processes, ensure sustainability, and determine its effect on MI-related morbidity and mortality.en_US
dc.subjectCardiac Catheter Laboratory Interventionen_US
dc.subjectST-Elevation Myocardial Infarctionen_US
dc.subjectCatheter Laboratoryen_US
dc.subjectCatheter Lab Activationen_US
dc.subjectCatheter Lab Transferen_US
dc.subjectThe Cardiac Society of Australia and New Zealand Guidelinesen_US
dc.subjectAcute Coronary Syndromesen_US
dc.subjectBest Practice Recommendationsen_US
dc.subjectInpatient Careen_US
dc.subjectInpatient Rapid MI Pathwayen_US
dc.subjectMyocardial Infarctionen_US
dc.subjectCardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleDevelopment and implementation of the inpatient rapid Myocardial Infarction (MI) Pathway at Epworth Richmond.en_US
dc.typeConference Posteren_US
dc.description.conferencenameEpworth HealthCare Research Week 2018en_US
dc.description.conferencelocationEpworth Research Institute, Victoria, Australiaen_US
Appears in Collections:Cardiac Sciences
Research Week

Files in This Item:
There are no files associated with this item.

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.